NCT07143448View on ClinicalTrials.gov

A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

January 31, 2028

Conditions

Pulmonary Arterial Hypertension

Interventions

BIOLOGICAL

HS235

Subcutaneous Injection

OTHER

Placebo

Subcutaneous Injection

Sponsors

Lead Sponsor

All Listed Sponsors

lead

35Pharma Inc

INDUSTRY